Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 774-784

  Zhao, Fengjuan ^a   Zhang, Qingyu ^a   Kang, Chunsheng ^a   Cui, Xiaowei ^a   Wang, Tao ^a   Xu, Peng ^a   Zhou, Xuan ^a   Liu, Jian ^a   Song, Xiaomei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Gene therapy; Growth; Invasion; Matrix metalloproteinase 9; RNA interference

Indexed keywords

CYCLINE; GELATINASE B; MATRIX METALLOPROTEINASE 9 SMALL INTERFERING RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGORIBONUCLEOTIDES, ANTISENSE; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956926254     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9285-x     Document Type: Article

References (36)

1. Y Tajima, et al. 2006 Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background Clin Cancer Res 12 21 6469 6479 10.1158/1078-0432.CCR-06-1339 17085661 (Pubitemid 44799720)
2. JL Ma, et al. 2006 Analysis of mortality trend of cancer from 1980 to 2002 in Linqu County Shandong Province Zhonghua Yufang Yixue Zazhi 40 6 405 408 17313740
3. A Giese R Bjerkvig ME Berens M Westphal 2003 Cost of migration: invasion of malignant gliomas and implications for treatment J Clin Oncol 21 8 1624 1636 10.1200/JCO.2003.05.063 12697889 (Pubitemid 46594118)
4. SG Li, et al. 2008 Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma World J Gastroenterol 14 3 421 427 10.3748/wjg.14.421 18200665 (Pubitemid 351320851)
5. JF Zhang, et al. 2005 DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma World J Gastroenterol 11 36 5592 5600 16237750
6. P Tummalapalli, et al. 2007 RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis Int J Oncol 31 5 1039 1050 17912429
7. S Kunigal SS Lakka CS Gondi N Estes JS Rao 2007 RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth Int J Cancer 121 10 2307 2316 10.1002/ijc.22962 17657740 (Pubitemid 47585614)
8. A Fire 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 6669 806 811 10.1038/35888 9486653 (Pubitemid 28099681)
9. S Akhtar, et al. 2000 The delivery of antisense therapeutics Adv Drug Deliv Rev 44 1 3 21 10.1016/S0169-409X(00)00080-6 11035194
10. MD Hughes M Hussain Q Nawaz P Sayyed S Akhtar 2001 The cellular delivery of antisense oligonucleotides and ribozymes Drug Discov Today 6 6 303 315 10.1016/S1359-6446(00)00326-3 11257582 (Pubitemid 32194667)
11. J Martinez A Patkaniowska H Urlaub R Lührmann T Tuschl 2002 Single-stranded antisense siRNAs guide target RNA cleavage in RNAi Cell 110 5 563 574 10.1016/S0092-8674(02)00908-X 12230974 (Pubitemid 35247837)
12. G Dirk AK Mark 2007 Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 117 12 3633 3641 10.1172/JCI34129 (Pubitemid 350224069)
13. R Almeida RC Allshire 2005 RNA silencing and genome regulation Trends Cell Biol 15 5 251 258 10.1016/j.tcb.2005.03.006 15866029 (Pubitemid 40603894)
14. H Zhang FA Kolb L Jaskiewicz E Westhof W Filipowicz 2004 Single processing center models for human Dicer and bacterial RNase III Cell 118 1 57 68 10.1016/j.cell.2004.06.017 15242644 (Pubitemid 38902814)
15. L Aagaard JJ Rossi 2007 RNAi therapeutics: principles, prospects and challenges Adv Drug Deliv Rev 59 2-3 75 86 10.1016/j.addr.2007.03.005 17449137 (Pubitemid 46770900)
16. G Tang 2005 siRNA and miRNA: an insight into RISCs Trends Biochem Sci 30 2 106 114 10.1016/j.tibs.2004.12.007 15691656 (Pubitemid 40187303)
17. DS Schwarz, et al. 2003 Asymmetry in the assembly of the RNAi enzyme complex Cell 115 2 199 208 10.1016/S0092-8674(03)00759-1 14567917 (Pubitemid 37329583)
18. FT Bosman I Stamenkovic 2003 Functional structure and composition of the extracellular matrix J Pathol 200 4 423 428 10.1002/path.1437 12845610 (Pubitemid 36818243)
19. JD Mott Z Werb 2004 Regulation of matrix biology by matrix metalloproteinases Curr Opin Cell Biol 16 5 558 564 10.1016/j.ceb.2004.07.010 15363807 (Pubitemid 39201241)
20. HJ Ra WC Parks 2007 Control of matrix metalloproteinase catalytic activity Matrix Biol 26 8 587 596 10.1016/j.matbio.2007.07.001 17669641 (Pubitemid 350180394)
21. H Birkedal-Hansen 1995 Proteolytic remodeling of extracellular matrix Curr Opin Cell Biol 7 5 728 735 10.1016/0955-0674(95)80116-2 8573349
22. V Lagente, et al. 2005 Role of matrix metalloproteinases in the development of airway inflammation and remodeling Braz J Med Biol Res 38 10 1521 1530 10.1590/S0100-879X2005001000009 16172745
23. H Nagase R Visse G Murphy 2006 Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 3 562 573 10.1016/j.cardiores. 2005.12.002 16405877 (Pubitemid 43139720)
24. CR Flannery 2006 MMPs and ADAMTSs: functional studies Front Biosci 11 544 569 10.2741/1818 16146752
25. TE Cawston AJ Wilson 2006 Understanding the role of tissue degrading enzymes and their inhibitors in development and disease Best Pract Res Clin Rheumatol 20 5 983 1002 10.1016/j.berh.2006.06.007 16980219 (Pubitemid 44356460)
26. CJ Malemud 2006 Matrix metalloproteinases (MMPs) in health and disease: an overview Front Biosci 11 1696 1701 10.2741/1915 16368548
27. SM Wilhelm, et al. 1989 SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages J Biol Chem 264 29 17213 17221 2551898
28. SE Daniels, et al. 1996 A genome-wide search for quantitative trait loci underlying asthma Nature 383 6597 247 250 10.1038/383247a0 8805698 (Pubitemid 26317671)
29. JJ Atkinson RM Senior 2003 Matrix metalloproteinase-9 in lung remodeling Am J Respir Cell Mol Biol 28 1 12 24 10.1165/rcmb.2002-0166TR 12495928 (Pubitemid 36017046)
30. JS Rao, et al. 2005 Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells Mol Cancer Ther 4 9 1399 1408 10.1158/1535-7163.MCT-05-0082 16170032
31. SS Lakka, et al. 2005 Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas J Biol Chem 280 23 21882 21892 10.1074/jbc.M408520200 15824107 (Pubitemid 40827839)
32. SR Jasti, et al. 2007 MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16INK4a and mitogen-activated protein kinase pathway Cancer Res 67 10 4956 4964 10.1158/0008-5472.CAN-07-0380 (Pubitemid 46910204)
33. YN Sun, et al. 2008 The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together Zhonghua Yi Xue Za Zhi 88 1 36 39 18346378
34. CS Gondi, et al. 2004 Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth Neuron Glia Biol 1 2 165 176 10.1017/S1740925X04000237 16804563
35. MG de Oliveira S Lauxen Ida AC Chaves PV Rados M Sant'Ana Filho 2008 Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions Med Oral Patol Oral Cir Bucal 13 5 E275 E280 18449109
36. A Prat E Casado J Cortés 2007 New approaches in angiogenic targeting for colorectal cancer World J Gastroenterol 13 44 5857 5866 17990351